Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the first quarter of 2024
Xintian Pharmaceutical: Announcement on Abnormal Fluctuations in Xintian Bond Transfer Transactions
Xintian Pharmaceutical: Announcement on the resumption of trading of the company's shares, the resumption of trading of convertible corporate bonds, and the conversion of shares
Xintian Pharmaceutical: Announcement on the suspension of trading and share conversion of Xintian Pharmaceutical during the suspension of trading of Xintian Pharmaceutical's stock trading
Xintian Pharmaceutical: Announcement on Not Early Redemption of Xintian Convertible Bonds
Xintian Pharmaceutical: Prompt Announcement on the Possible Satisfaction of Xintian Transfer Bonds to Redemption Requirements
Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the fourth quarter of 2023
Xintian Pharmaceutical: 2023 Interest Payment Announcement on Convertible Corporate Bonds
Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2023
Xintian Pharmaceutical: Notice on not redeeming “Xintian Convertible Bonds” in advance
Xintian Pharmaceutical: Prompt Announcement on the Possible Satisfaction of Xintian Transfer Bonds to Redemption Requirements
Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds in the second quarter of 2023
Xintian Pharmaceutical: Prompt Announcement on the Price Adjustment of Xintianzuan Debt-to-Shares
Xintian Pharmaceutical: Announcement on the 2023 tracking rating results of convertible corporate bonds
Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the first quarter of 2023
Xintian Pharmaceutical: Announcement on not redeeming Xintian Swap Bonds early
Xintian Pharmaceutical: Prompt Announcement on the Possible Satisfaction of Xintian Transfer Bonds to Redemption Requirements
Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the fourth quarter of 2022
Xintian Pharmaceutical: 2022 Interest Payment Announcement on Convertible Corporate Bonds
Xintian Pharmaceutical: Prompt Announcement on the Price Adjustment of Xintianzuan Debt-to-Shares